Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK
Portfolio Pulse from
Levi & Korsinsky has filed a class action securities lawsuit against Merck (MRK) alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 21, 2025 | 10:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck's stock may experience continued volatility due to the class action lawsuit alleging securities fraud related to Gardasil sales projections in China.
The lawsuit alleges material misrepresentation of Gardasil sales forecasts, which already caused a 9% stock drop and could lead to further legal and financial consequences.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100